The Evolving Post-Marketing World: Key Takeaways from ISPOR 16th Annual European Congress

UBC experts provided key insights at ISPOR 16th Annual European Congress

The Evolving Post-Marketing World: Key Takeaways from ISPOR 16th Annual European Congress

ISPOR 16th Annual European Congress, held November 2-6 in Dublin, was a great success, providing the opportunity for thought-provoking presentations as well as valuable networking and information sharing.

Industry thought leaders participated in a panel that explored patient-reported outcomes and how best to incorporate them in EMA and FDA safety mandates. Additionally, our UBC experts presented a number of abstracts throughout the conferences.

If you were unable to attend, you may still benefit from much of the research and insights presented by viewing many of the presentations online.

Be sure to check out our workshop: 

Introducing Patient-Reported Outcomes Into EMA-Mandated Post-Authorization Safety Studies and FDA-Mandated Post-Marketing Safety Commitment, given by Annette Stemhagen, DrPH, FISPE, Senior Vice President, Epidemiology and Risk Management, UBC;  Janine Collins, MD, Senior Director European Risk Management, UBC; Krista Payne, Med, Executive Director, Sr. Research Scientist, Value Demonstration; and Brian David Edwards, MD, MRCP, Principal Consultant, Pharmacovigilance, NDA Regulatory Science Ltd., Leatherhead, UK.